Literature DB >> 15802214

Life-threatening erythroderma: diagnosing and treating the "red man".

Marti Jill Rothe1, Megan L Bernstein, Jane M Grant-Kels.   

Abstract

Exfoliative erythroderma, or diffuse erythema and scaling of the skin, may be the morphologic presentation of a variety of cutaneous and systemic diseases. Establishing the diagnosis of the underlying disease is often difficult and, not uncommonly, erythroderma is classified as idiopathic. Several cases are presented to demonstrate the diversity of presentation of this disease. Laboratory findings are typically unhelpful in establishing the etiology of erythroderma. Clinical data combined with multiple skin biopsies over time are necessary. Systemic complications of erythroderma include infection, fluid and electrolyte imbalances, thermoregulatory disturbance, high output cardiac failure, and acute respiratory distress syndrome. The initial approach to the management of erythroderma of any etiology includes attention to nutrition, fluid and electrolyte replacement, and the institution of gentle local skin care measures. Oatmeal baths and wet dressings to weeping or crusted sites should be followed by application of bland emollients and low-potency topical corticosteroids. Systemic dermatologic therapy may be required to maintain improvement achieved with local measures or to control erythroderma refractory to local measures. The prognosis of erythroderma is dependent on the underlying etiology.

Entities:  

Mesh:

Year:  2005        PMID: 15802214     DOI: 10.1016/j.clindermatol.2004.06.018

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  12 in total

Review 1.  Chemotherapy improves thymoma-associated graft-versus-host-disease-like erythroderma.

Authors:  Tatsuya Nagano; Yoshikazu Kotani; Kazuyuki Kobayashi; Nanako Tomita; Kyosuke Nakata; Akihiro Sakashita; Yasuhiro Funada; Hiroshi Nagai; Tomoo Itoh; Yoshihiro Nishimura
Journal:  BMJ Case Rep       Date:  2011-05-10

2.  Exfoliative Dermatitis as a Para-neoplastic Syndrome of Prostate Adenocarcinoma: A Rare Case Report With Literature Review.

Authors:  Sayed Reshad Ghafouri; Abelardo Escriba-Omar; Inayatullah Wahdatyar; Noah Whited; Mohammad Nawar Hakim; Sumit Gaur; Fatma Dihowm
Journal:  Cancer Diagn Progn       Date:  2021-07-03

3.  Erythrodermic scabies in an immunocompetent patient.

Authors:  Ronan Talty; Goran Micevic; William Damsky; Brett A King
Journal:  JAAD Case Rep       Date:  2022-09-08

Review 4.  Cutaneous Drug Reactions in the Elderly.

Authors:  James W S Young; Neil H Shear
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 4.271

5.  A Suspected Case of Silodosin-Induced Erythroderma.

Authors:  Annie Liu; Lyne Giroux
Journal:  Drug Saf Case Rep       Date:  2015-12

6.  Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center.

Authors:  Denis Miyashiro; José Antonio Sanches
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379

7.  Erythroderma: review of a potentially life-threatening dermatosis.

Authors:  Cynthia Okoduwa; W C Lambert; R A Schwartz; E Kubeyinje; A Eitokpah; Smeeta Sinha; W Chen
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

8.  Ayurvedic management of life-threatening skin emergency erythroderma: A case study.

Authors:  Sarvesh Kumar Singh; Kshipra Rajoria
Journal:  Ayu       Date:  2015 Jan-Mar

9.  A Study of Correlation Between Clinical and Histopathological Findings of Erythroderma in North Bengal Population.

Authors:  Sabyasachi Banerjee; Swarup Ghosh; Rajesh Kumar Mandal
Journal:  Indian J Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.494

10.  Erythrodermic Psoriasis Treated with Apremilast.

Authors:  John Arcilla; Daniel Joe; Johnathan Kim; Yohanan Kim; VuAnh N Truong; Navin Jaipaul
Journal:  Dermatol Reports       Date:  2016-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.